Actively Recruiting
Research on the Effectiveness of Using Decision Cycle for Person-Centered Glycemic Management on Self-Care Behaviors in Outpatients With Type 2 Diabetes
Led by National Taiwan University Hospital · Updated on 2025-02-12
130
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating a new approach called the Decision Cycle for Person-Centered Glycemic Management in people with type 2 diabetes. This method, recommended by the American Diabetes Association and the European Association for the Study of Diabetes, focuses on creating treatment goals and plans based on each patient's personal preferences, values, and goals. The study aims to improve patients' self-care behaviors and lower glycated hemoglobin levels to delay complications. Participants will be divided into two groups: one receiving the Decision Cycle for Person-Centered Glycemic Management, which is a holistic, patient-focused care intervention, and the other receiving traditional diabetes self-management education, which is more educator-centered and focuses on teaching knowledge and skills. The study will compare these two approaches to see which better improves self-care and blood sugar control. Participants will be tested before and three months after the intervention to measure changes in glycated hemoglobin (HbA1c) and self-care behaviors using a specific scale. Researchers will monitor these outcomes to assess the effectiveness of the Decision Cycle approach. The study is expected to continue until the end of 2025, with ongoing evaluation and support throughout the participation period.
CONDITIONS
Brief Title
Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with type 2 diabetes by a physician.
- Age 18 years or above.
- Glycated hemoglobin (HbA1c) value between 7.5% and 9.0%.
- No change in diabetic oral medications, insulin, or glucagon-like peptide-1 at outpatient admission.
- Not pregnant during the study period.
- Agree to join the study after explanation.
- Conscious and able to take care of themselves.
- No diagnosis of mental illness per DSM-IV.
- Able to communicate in Mandarin and Taiwanese.
You will not qualify if you...
- Diagnosed with type 1 diabetes by a physician.
- Under 18 years old.
- Glycated hemoglobin (HbA1c) less than 7.5% or greater than 9.0%.
- Changed oral diabetes medications, insulin, or glucagon-like peptide-1 at outpatient admission.
- Pregnant during the study period.
- Unable to take care of themselves or express themselves.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single intervention period lasting up to 3 months
Participants receive diabetes self-management education based on their assigned group, either a person-centered decision cycle approach or traditional educator-centered education.
1 baseline visit and 1 post-intervention visit
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Hsinchu, Taiwan, 302
Actively Recruiting
Research Team
C
Chia-Hui Tsai
K
Kang-Chih Fan
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here